{"slug":"viatris","name":"비아트리스","name_en":"Viatris","ticker":"VTRS","updated_at":"2026-07-11T10:15:43.023+00:00","canonical":"https://valuechain.wiki/viatris","kicker":"헬스케어 · S&P 500","kicker_en":"Health Care · S&P 500","lead":"비아트리스는 마일란과 화이자 업존 합병으로 탄생한 글로벌 제네릭·복제약 제약 기업이다. S&P 500 구성종목. 섹터: 헬스케어(Pharmaceuticals). 밸류체인 관계·수치 데이터는 조사 전인 기본 노드로, AI 질문 수요가 관측되면 상세 노드로 승격된다.","lead_en":"Viatris is a global generics-focused pharmaceutical company formed by the merger of Mylan and Pfizer's Upjohn. S&P 500 constituent. Sector: Health Care (Pharmaceuticals). Baseline node ahead of value-chain research; promoted to a full node once AI question demand is observed.","segments":{"parts":[{"name":"선진 시장"},{"name":"신흥 시장"},{"name":"중화권"}],"total":"약 $14.7B (FY2024)"},"segments_en":{"parts":[{"name":"Developed Markets"},{"name":"Emerging Markets"},{"name":"Greater China"}],"total":"approx. $14.7B (FY2024)"},"returns_yearly":{"2021":-26.1,"2022":-14.3,"2023":2.1,"2024":19.7,"2025":5.1,"2026":32.8},"return_asof":"2026-07-10","value_chain":{"leading":[],"benefiting":[],"analysis":null,"analysis_en":null,"analysis_asof":null},"edges":[]}